Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Tools
Werbung:
Marktanalyse - Cough, Cold and Allergy (hay Fever) Remedies - South Africa
Market Direction
Euromonitor
7 / 2010
40 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | South Africa |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
An outbreak of the H1N1 (swine flu) raised the concerns of many consumers. South Africa had no choice but to develop its own flu vaccine to combat the virus, as first world countries opted to cover their own populations before making the vaccine available to the developing world. Approximately 5,000 cases were reported in South Africa and 15 people died from it. In anticipation, consumers used OTC products in an attempt to alleviate cold and flu symptoms.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Cough, Cold and Allergy (hay Fever) Remedies in South Africa
Euromonitor International
July 2010
List of Contents and Tables
Executive Summary
Steady Growth in Challenging Retail Environment
Self-medication Plays Major Role in Volume Sales
OTC Sales Dominated by A Small Number of Players
Grocery Channels Increase Footprint
Health Concerns at the Forefront of Consumers' Minds
Key Trends and Developments
In-store Pharmacies Expand Footprint
Recession Forces Companies To Increase Their Advertising Campaigns
Increased Self-medication Expands Untrustworthy Trade Footprint
Hiv/aids Symptoms and Side-effects Elevate OTC Sales
Growing Appeal for Natural/herbal Variants
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Consumer Health Switches in 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Adcock Ingram Ltd
Strategic Direction
Key Facts
Summary 3 Adcock Ingram Ltd: Key Facts
Summary 4 Adcock Ingram Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Adcock Ingram Ltd: Competitive Position 2009
Aspen Pharmacare (pty) Ltd
Strategic Direction
Key Facts
Summary 6 Aspen Pharmacare (Pty) Ltd: Key Facts
Summary 7 Aspen Pharmacare (Pty) Ltd - SA Pharmaceutical Division: Operational Indicators2
Company Background
Production
Competitive Positioning
Summary 8 Aspen Pharmacare: Competitive Position 2009
Bioscience Brands Ltd
Strategic Direction
Key Facts
Summary 9 Bioscience Ltd: Key Facts
Summary 10 Bioscience Ltd: Number of employees
Company Background
Production
Competitive Positioning
Summary 11 Bioscience Brands (Pty) Ltd: Competitive Position 2009
Cipla-medpro (pty) Ltd
Strategic Direction
Key Facts
Summary 12 Cipla-Medpro (Pty) Ltd: Key Facts
Summary 13 Cipla-Medpro (Pty) Ltd Limited: Operational Indicators
Company Background
Production
Competitive Positioning
Dischem (pty) Ltd
Strategic Direction
Key Facts
Summary 14 Dis-Chem (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Novartis South Africa (pty) Ltd
Strategic Direction
Key Facts
Summary 15 Novartis South Africa (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Novartis South Africa (Pty) Ltd: Competitive Position 2009
Vital Health Foods (pty) Ltd
Strategic Direction
Key Facts
Summary 17 Vital Health Foods (Pty) Ltd: Key Facts
Company Background
Competitive Positioning
Summary 18 Vital Health Foods (Pty) Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009
Table 14 Sales of Decongestants by Type: Value 2004-2009
Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014
Euromonitor International
July 2010
List of Contents and Tables
Executive Summary
Steady Growth in Challenging Retail Environment
Self-medication Plays Major Role in Volume Sales
OTC Sales Dominated by A Small Number of Players
Grocery Channels Increase Footprint
Health Concerns at the Forefront of Consumers' Minds
Key Trends and Developments
In-store Pharmacies Expand Footprint
Recession Forces Companies To Increase Their Advertising Campaigns
Increased Self-medication Expands Untrustworthy Trade Footprint
Hiv/aids Symptoms and Side-effects Elevate OTC Sales
Growing Appeal for Natural/herbal Variants
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Consumer Health Switches in 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Adcock Ingram Ltd
Strategic Direction
Key Facts
Summary 3 Adcock Ingram Ltd: Key Facts
Summary 4 Adcock Ingram Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Adcock Ingram Ltd: Competitive Position 2009
Aspen Pharmacare (pty) Ltd
Strategic Direction
Key Facts
Summary 6 Aspen Pharmacare (Pty) Ltd: Key Facts
Summary 7 Aspen Pharmacare (Pty) Ltd - SA Pharmaceutical Division: Operational Indicators2
Company Background
Production
Competitive Positioning
Summary 8 Aspen Pharmacare: Competitive Position 2009
Bioscience Brands Ltd
Strategic Direction
Key Facts
Summary 9 Bioscience Ltd: Key Facts
Summary 10 Bioscience Ltd: Number of employees
Company Background
Production
Competitive Positioning
Summary 11 Bioscience Brands (Pty) Ltd: Competitive Position 2009
Cipla-medpro (pty) Ltd
Strategic Direction
Key Facts
Summary 12 Cipla-Medpro (Pty) Ltd: Key Facts
Summary 13 Cipla-Medpro (Pty) Ltd Limited: Operational Indicators
Company Background
Production
Competitive Positioning
Dischem (pty) Ltd
Strategic Direction
Key Facts
Summary 14 Dis-Chem (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Novartis South Africa (pty) Ltd
Strategic Direction
Key Facts
Summary 15 Novartis South Africa (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Novartis South Africa (Pty) Ltd: Competitive Position 2009
Vital Health Foods (pty) Ltd
Strategic Direction
Key Facts
Summary 17 Vital Health Foods (Pty) Ltd: Key Facts
Company Background
Competitive Positioning
Summary 18 Vital Health Foods (Pty) Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009
Table 14 Sales of Decongestants by Type: Value 2004-2009
Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014
- Grass Pollen Allergy – Pipeline Review, H1 2013
- House Dust Mite Allergy – Pipeline Review, H1 2013
- Cough, Cold and Allergy (Hay Fever) Remedies in Australia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Egypt
- Cough, Cold and Allergy (Hay Fever) Remedies in Romania
- Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia
- Cough, Cold and Allergy (Hay Fever) Remedies in Kenya
- Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Portugal
- Allergies – Pipeline Review, H2 2012
- Cough, Cold and Allergy (Hay Fever) Remedies in Iran
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands
- Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam
- Peanut Allergy – Pipeline Review, H2 2012
- Pollen Allergy – Pipeline Review, H2 2012
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:


